GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors

By sjmartinez • September 1, 2024

Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi S, Bhatt DL, Dani S, Nohria A, Butler J, Ganatra S. GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors. JACC Heart Fail. 2024 Aug 16:S2213-1779(24)00561-4. doi: 10.1016/j.jchf.2024.07.006. Epub ahead of print. PMID: 39207323.

Tags: Cardiology/Epi, GLP-1 receptor agonists, Heart failure with preserved ejection fraction, Obesity, overweight, Publications, SGLT2is

Heart Failure and Gut Microbiota: What Is Cause and Effect?

Shen S, Tian B, Zhang H, Wang YC, Li T, Cao Y. Heart Failure and Gut Microbiota: What Is Cause and Effect? Research (Wash D[...]

Amara Yad Image: Myocardial Scar

Mori S, Fishbein MC, Shivkumar K. Amara Yad Image: Myocardial Scar. J Am Coll Cardiol. 2025 Feb 25;85(7):782-783. doi: 10.1016/j.jacc.2025.01.004. PMID: 39971411.

Comparative Predictors of Mortality Risk in Contemporary Patients Referred for Stress Myocardial Perfusion Imaging

Rozanski A, Gransar H, Miller RJH, Han D, Hayes SW, Friedman JD, Thomson L, Lavie CJ, Berman DS. Comparative Predictors of Mortality Risk in Contemporary[...]